Nuvectra Corporation (NVTR) financial statements (2021 and earlier)

Company profile

Business Address 5830 GRANITE PKWY
PLANO, TX 75024
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments992864
Cash and cash equivalents992864
Receivables12113
Inventory, net of allowances, customer advances and progress billings755
Inventory755
Other undisclosed current assets110
Total current assets:1194573
Noncurrent Assets
Property, plant and equipment566
Intangible assets, net (including goodwill)334040
Goodwill333838
Intangible assets, net (excluding goodwill) 12
Other noncurrent assets 01
Total noncurrent assets:394647
TOTAL ASSETS:15891119
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities211515
Accounts payable8210
Accrued liabilities693
Employee-related liabilities742
Debt 1 
Deferred compensation liability  1
Total current liabilities:211616
Noncurrent Liabilities
Long-term debt and lease obligation442614
Long-term debt, excluding current maturities442614
Liabilities, other than long-term debt011
Other liabilities011
Total noncurrent liabilities:452715
Total liabilities:654331
Stockholders' equity
Stockholders' equity attributable to parent934889
Common stock000
Additional paid in capital219126122
Accumulated other comprehensive income (loss)0(0)(0)
Accumulated deficit(126)(78)(33)
Total stockholders' equity:934889
TOTAL LIABILITIES AND EQUITY:15891119

Income statement (P&L) ($ in millions)

12/31/2018
12/31/2017
12/31/2016
Revenues493213
Revenue, net3213
Cost of revenue
(Cost of Goods and Services Sold)
(23)(16)(6)
Gross profit:26166
Operating expenses(69)(58)(44)
Operating loss:(43)(42)(37)
Nonoperating income (expense)1(1)0
Investment income, nonoperating1  
Other nonoperating income (expense)(0)(1)0
Interest and debt expense(5)(2)(1)
Loss from continuing operations before equity method investments, income taxes:(47)(45)(39)
Other undisclosed income from continuing operations before income taxes000
Loss from continuing operations before income taxes:(47)(45)(38)
Income tax expense (benefit)0(0) 
Loss from continuing operations:(47)(45)(38)
Loss from discontinued operations(1)  
Net loss available to common stockholders, diluted:(48)(45)(38)

Comprehensive Income ($ in millions)

12/31/2018
12/31/2017
12/31/2016
Net loss:(48)(45)(38)
Comprehensive loss:(48)(45)(38)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent00(0)
Comprehensive loss, net of tax, attributable to parent:(48)(45)(38)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: